BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240610
DTEND;VALUE=DATE:20240613
DTSTAMP:20260515T200317
CREATED:20240215T112047Z
LAST-MODIFIED:20240215T112047Z
UID:38716-1717977600-1718236799@www.pharmajournalist.com
SUMMARY:6th Allogeneic Cell Therapies Summit
DESCRIPTION:The entire cell therapy field is experiencing a shift towards allogeneic platforms as the potential to achieve a truly off-the-shelf\, universal\, and efficacious cell therapy offers great advantages such as reduced cost\, production and patient accessibility compared to its autologous counterparts. \nPlacing a spotlight on what has been deemed the ‘future of cell therapy’\, the 6th Annual Allogeneic Cell Therapies Summit returns to Boston this June as the leading industry focused meeting dedicated to accelerating the safety\, durability and clinical translation of off-the-shelf therapies to deliver affordable and accessible treatments for patients in critical need. \nAcross a jam-packed agenda consisting of 60+ hours of content\, 3 in-depth tracks\, 1 Investor & Business Development Focus Day\, 1 Beyond Oncology Bootcamp Day and more; our 50+ expert speakers will lead you and your peers in discussions that will help to transform universal cell therapies for patients across the globe. \nLearn more here: https://ter.li/aetc0d
URL:http://www.pharmajournalist.com/event/6th-allogeneic-cell-therapies-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240611
DTEND;VALUE=DATE:20240614
DTSTAMP:20260515T200317
CREATED:20240208T112624Z
LAST-MODIFIED:20240208T112624Z
UID:38638-1718064000-1718323199@www.pharmajournalist.com
SUMMARY:3rd Process Development for Cell Therapies Summit
DESCRIPTION:Driving Process Robustness\, Scalability\, Speed & Affordability \nIn the dynamic cell therapy landscape\, where financial challenges continue to prevail\, the emphasis on innovative process development becomes pivotal. Now\, more than ever\, there’s a heightened demand for cost-effective solutions that bolster scalability and expedite development timelines. \nWelcome to the 3rd Process Development for Cell Therapies Summit\, your paramount gathering dedicated to advancing process robustness\, scalability\, speed\, and affordability. This ensures the rapid advancement of highly efficacious products through clinical trials\, securing a market-ready status with competitive commercial viability. \nWhether you’re on the brink of IND or gearing up for BLA submission\, this gathering of brilliant minds offers an unparalleled opportunity to glean insights form organizations like BMS\, Beam Therapeutics\, 2seventy Bio\, Takeda\, Century Therapeutics\, AstraZeneca\, and more! \nSeize this opportunity to connect with technical experts united in the goal of streamlining process development. Through the sharing of best practices and pre-competitive insights\, let’s collectively drive the streamlined development of consistent\, scalable\, and cost-effective autologous and allogeneic cell therapies. Together\, we can shape the future of cell therapy! \nTo know more visit: https://ter.li/ixkr7z
URL:http://www.pharmajournalist.com/event/3rd-process-development-for-cell-therapies-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240611
DTEND;VALUE=DATE:20240614
DTSTAMP:20260515T200317
CREATED:20240208T113943Z
LAST-MODIFIED:20240222T125925Z
UID:38641-1718064000-1718323199@www.pharmajournalist.com
SUMMARY:Structure-Based Drug Design Summit
DESCRIPTION:Harnessing Integrative Structural Biology Techniques Including NMR\, X-Ray Crystallography\, Cryo-EM\, & Cryo-ET to Determine 3D Structures of Pharmacologically Relevant Targets & Propel Drug Design \nHave you heard the boom created by Cryo-EM? Drug development has been shaken up with the application of Cryo-EM\, accelerating and increasing the rate of success of protein targeting by identifying new ways to treat diseases with greater sensitivity and efficiency in the study of 3D structures. Structural biologists\, medicinal chemists\, and computational chemists need to assess the experimental methods by sharing case study presentations to streamline\, rationalize\, and optimize drug design. \nThe inaugural Structure-Based Drug Design Summit  is your opportunity to assess the resolution and speed of the techniques in the toolbox to answer structural biology questions for drug design\, assess the gaps\, and implement newer techniques for increased specificity and precision \nSharing cutting-edge structural biology methods and applications\, including harnessing Cryo-EM and Cryo-ET to visualize protein interactions\, structure-based methods as a package of techniques to study integrated biological systems\, and incorporating computational methods as a predictive tool for structures; this is a unique opportunity to come together and rationalize drug design by understanding the 3D structure of proteins. Join 50+ industry scientists to delve into 3D protein structure determination using NMR\, X-Ray Crystallography\, Cryo-EM\, and Cryo-ET\, to improve resolution and efficiency and rationalize drug development. \nRevolutionize the way drugs are discovered and developed to lead to newer and more effective therapeutics for a wide range of diseases\, build the complete 3D picture\, and go after undruggable targets.
URL:http://www.pharmajournalist.com/event/structure-based-drug-design-summit/
LOCATION:Embassy Suites by Hilton Boston at Logan Airport\, 207 Porter St\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240611
DTEND;VALUE=DATE:20240614
DTSTAMP:20260515T200317
CREATED:20240321T115006Z
LAST-MODIFIED:20240321T115126Z
UID:38904-1718064000-1718323199@www.pharmajournalist.com
SUMMARY:6th Age-Related Disease Therapeutics Summit
DESCRIPTION:The 6th Age-Related Disease Therapeutics Summit is returning to San Francisco in June\, with 60+ participants including Eli Lilly\, Takeda\, and Turn Biosciences to dive deep into breakthroughs in cellular programming\, senolytic pathways\, and epigenetic effects. Explore biomarkers\, navigate regulations\, and foster collaborations for pipeline support and commercialization. \nThis is your definitive age-related disease therapeutics forum to gain unparalleled competitive intelligence\, scientific advancements and form meaningful partnerships to solve humankind’s fundamental problem.
URL:http://www.pharmajournalist.com/event/6th-age-related-disease-therapeutics-summit/
LOCATION:Hyatt Centric Fisherman’s Wharf\, 555 North Point Street\, San Francsico\, CA\, 94133\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240612
DTEND;VALUE=DATE:20240615
DTSTAMP:20260515T200317
CREATED:20240410T111557Z
LAST-MODIFIED:20240411T111540Z
UID:38976-1718150400-1718409599@www.pharmajournalist.com
SUMMARY:4th Next Generation Gene Therapy Vectors Summit
DESCRIPTION:Accelerate your capsid and payload design with the 4th Next Generation Gene Therapy Vectors Summit (June 12-14\, Boston) \nAs a recent whitepaper by the Alliance for Regenerative Medicine cites capsid engineering and disruptive delivery platforms as key emerging technologies in the CGT space\, drug developers are heavily investing in finding and optimizing the safety\, efficacy\, and predictability of delivery platforms. \nThis is 2024’s only meeting covering the latest advances and innovations in vector development for gene therapies\, uniting 90+ R&D and business development leaders to advance cutting-edge delivery platforms into the clinic. Data-driven talks\, expert panels\, and interactive group discussions led by 25+ industry experts will provide you with the ‘latest and greatest’ in both disruptive viral and non-viral vectors. \nJoin us to gain actionable insights in how to enable targeted gene delivery\, reduce immunogenicity & toxicity\, enhance downstream manufacturability\, expand packaging capabilities\, and secure funding and investment for your own vector platform. \nWant to learn more? Check out the event guide here https://ter.li/nnkbb3
URL:http://www.pharmajournalist.com/event/4th-next-generation-gene-therapy-vectors-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR